AXIM BIOTECHNOLOGIES, INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$3.83 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-23.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2021-08-23
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-06-30 was -$3.83M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-03-31 was -$864.54K.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-09-30 was -$1.91M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-06-30 was -$79.39K.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2020 was -$6.41M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2019 was -$6.45M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2018 was -$6.75M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2017 was -$4.17M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$3.83M 10-Q · filed 2021-08-23 | -$4.69M derived: sum of 2 quarters · filed 2021-08-23 | ||
| 2021-03-31 | -$864.54K 10-Q · filed 2021-08-23 | |||
| 2020-12-31 | -$6.41M 10-K/A · filed 2021-04-26 | |||
| 2020-09-30 | -$1.91M 10-Q/A · filed 2020-11-27 | -$1.98M derived: sum of 2 quarters · filed 2021-08-23 | -$4.01M derived: sum of 3 quarters · filed 2021-08-23 | |
| 2020-06-30 | -$79.39K 10-Q · filed 2021-08-23 | -$2.11M derived: sum of 2 quarters · filed 2021-08-23 | ||
| 2020-03-31 | -$2.03M 10-Q · filed 2021-08-23 | |||
| 2019-12-31 | -$6.45M 10-K/A · filed 2021-04-26 | |||
| 2019-09-30 | -$863.62K 10-Q/A · filed 2020-11-27 | -$2.67M derived: sum of 2 quarters · filed 2020-11-27 | -$5.01M derived: sum of 3 quarters · filed 2020-11-27 | -$5.99M derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-06-30 | -$1.81M 10-Q/A · filed 2020-11-27 | -$4.15M derived: sum of 2 quarters · filed 2020-11-27 | -$5.13M derived: sum of 3 quarters · filed 2020-11-27 | -$6.46M derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-03-31 | -$2.34M 10-Q/A · filed 2020-11-27 | -$3.32M derived: sum of 2 quarters · filed 2020-11-27 | -$4.66M derived: sum of 3 quarters · filed 2020-11-27 | -$6.33M derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-12-31 | -$978.89K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | -$2.31M derived: sum of 2 quarters · filed 2020-05-20 | -$3.99M derived: sum of 3 quarters · filed 2020-05-20 | -$6.75M 10-K/A · filed 2020-05-20 |
| 2018-09-30 | -$1.33M 10-Q · filed 2019-11-14 | -$3.01M derived: sum of 2 quarters · filed 2019-11-14 | -$5.78M 10-Q · filed 2018-11-14 | -$7.21M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$1.68M 10-Q · filed 2019-11-14 | -$4.44M 10-Q · filed 2018-08-17 | -$5.88M derived: sum of 3 quarters · filed 2019-11-14 | -$7.52M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-03-31 | -$2.76M 10-Q · filed 2019-11-14 | -$4.20M derived: sum of 2 quarters · filed 2019-11-14 | -$5.84M derived: sum of 3 quarters · filed 2019-11-14 | |
| 2017-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-08 | -$3.08M derived: sum of 2 quarters · filed 2019-04-08 | -$4.17M 10-K · filed 2019-04-08 | |
| 2017-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$2.73M 10-Q · filed 2017-11-20 | ||
| 2017-06-30 | -$1.09M 10-Q · filed 2017-09-14 | |||
| 2016-12-31 | -$5.81M 10-K · filed 2018-03-15 |